By investigating antibody and T cell responses to a single dose of the Oxford–AstraZeneca COVID-19 vaccine, researchers from Sri Lanka
Continue reading »
mypharmacynews.com
Home »
By investigating antibody and T cell responses to a single dose of the Oxford–AstraZeneca COVID-19 vaccine, researchers from Sri Lanka
Continue reading »A study conducted at the University of Campinas (UNICAMP) in the state of São Paulo, Brazil, shows that compounds produced
Continue reading »Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern are characterized by mutations in the receptor-binding domain and
Continue reading »Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern are characterized by mutations in the receptor-binding domain and
Continue reading »Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative pathogen of the ongoing coronavirus disease 2019 (COVID-19) pandemic. The
Continue reading »In a study aimed at investigating the mechanism responsible for exacerbating rheumatoid arthritis in smokers, researchers at the Center for
Continue reading »A new study uncovers which cell types can be infected by SARS-CoV-2 due to their viral entry factors. The study
Continue reading »Mount Sinai Researchers find a new way to prevent attention deficits associated with Fragile X, a leading genetic cause of
Continue reading »A study recently conducted at the Jenner Institute, University of Oxford, UK, has investigated the significance of a transmembrane glycoprotein
Continue reading »Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) pandemic has placed a significant
Continue reading »